Dr. Meena Madhur is the Division Chief of Clinical Pharmacology and Associate Professor of Medicine with a secondary appointment in the Department of Anatomy, Cell Biology, and Physiology at Indiana University. She graduated summa cum laude from Duke University where she double majored in Biomedical Engineering and Biology. She then joined the University of Virginia Medical Scientist Training Program where she received her MD and PhD degrees, graduating with Alpha Omega Alpha honors. She returned to Duke University for her training in Internal Medicine and completed her Cardiology fellowship at Emory University.

She then joined the faculty at Vanderbilt as an Assistant Professor in 2012, rising through the ranks and obtaining tenure in 2020. She recently moved to Indiana University in August 2023 to lead their Division of Clinical Pharmacology. Dr. Madhur’s research focuses on the interplay between the immune system and hypertension, including renal, vascular, and cardiac complications of hypertension. Her long-term goal is to identify novel diagnostic and therapeutic strategies for hypertension and heart failure. Dr. Madhur’s laboratory has been continuously funded by the National Institutes of Health (NIH) and American Heart Association (AHA) for the past 12 years. She has received numerous awards and honors including the American Society of Clinical Investigation (ASCI) Young Physician-Scientist Award, AHA Hypertension Council Harry Goldblatt New Investigator Award, AHA Established Investigator Award, the International Society of Hypertension Mid Career Award for Women Researchers, an NIH DP2 New Innovator Award, a Presidential Early Career Award for Scientists and Engineers (PECASE), and an AHA Hypertension Council Mid-Career Award. In addition, she is a fellow of the AHA (FAHA), fellow of the American College of Cardiology (FACC), and member of the ASCI.

She currently serves as Guest Editor of the journal Hypertension and Associate Editor of Clinical Science.